Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-08

Clinical Trial Update: Gentamicin Intravesical Efficacy for Infection of Urinary Tract [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intravesical gentamicin for postoperative urinary tract infection; study completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gentamicin (gentamicin)

Snippet

Sponsor: Kaiser Permanente | Conditions: Postoperative Urinary Tract Infection, Pelvic Organ Prolapse | Phase 2 | Status: COMPLETED | Results posted: 2022-11-08